Inclusion body myositis
Slowly progressive refractory myopathy · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
The commonest acquired myopathy over age 50, characterised by slowly progressive, often asymmetric weakness affecting finger flexors and quadriceps with early dysphagia. It is largely refractory to immunosuppression, so recognition avoids inappropriate long-term steroids.
Red flags
- Significant dysphagia with aspiration or weight loss
- Recurrent falls from quadriceps weakness
- Rapid progression (suggests alternative diagnosis)
- Respiratory muscle involvement (late)
- Features suggesting motor neurone disease
Assessment
Differential diagnosis
- Polymyositis
- Immune-mediated necrotising myopathy
- Motor neurone disease
- Muscular dystrophy (late-onset)
- Inclusion body myositis mimics (anti-cN1A negative cases)
- Diabetic amyotrophy
Investigations
- Creatine kinase (normal or mildly raised, usually <15x)
- EMG (mixed myopathic and neurogenic features)
- Muscle biopsy (rimmed vacuoles, endomysial inflammation, protein aggregates)
- Anti-cN1A (NT5C1A) antibody
- MRI showing selective muscle involvement (forearm flexors, quadriceps)
- Swallow assessment / videofluoroscopy for dysphagia
Management
- Suspect in an older patient with painless, asymmetric finger-flexor and quadriceps weakness and dysphagia
- Document functional impairment (grip, stairs, swallowing, falls)
- Confirm with EMG and muscle biopsy; test anti-cN1A
- Distinguish from treatable myositis to avoid futile immunosuppression
- Trial immunosuppression only if diagnostic doubt or significant inflammatory overlap, and stop if no response
- Refer for swallow assessment and dietetic input for dysphagia
- Arrange physiotherapy, occupational therapy, falls prevention and aids
- Provide genetic counselling for hereditary IBM mimics where relevant
Drugs & doses
No disease-modifying drug is proven effective; immunosuppression generally not recommended
Prednisolone — 0.75 mg/kg/day PO only as a time-limited trial if inflammatory overlap, discontinue if no benefit
IVIG — 2 g/kg over 2-5 days may transiently help dysphagia in selected cases
Supportive: physiotherapy, orthoses and swallow therapy
Disposition
Outpatient rheumatology/neurology with multidisciplinary support; admit only for aspiration or acute swallowing failure.
Complications & pitfalls
- Aspiration pneumonia
- Falls and fractures
- Progressive disability and loss of independence
- Malnutrition from dysphagia
- Unnecessary steroid toxicity if misdiagnosed
Exam pearls
- Classic pattern: weak finger flexors (weak grip) with preserved shoulder abduction, and weak quadriceps
- CK is only mildly elevated - very high CK suggests an alternative
- Largely steroid-resistant - the main value of diagnosis is to avoid harm
- Dysphagia is common and may respond to cricopharyngeal intervention
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.